Delivery Order SPE2DB22D3501-SPE2DB25FXF25
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. This firm fixed-price delivery order, valued at $3,020.08, was competitively awarded without set-aside restrictions and is scheduled for completion by July 21, 2025. The order was placed on July 18, 2025, and will be fulfilled from the vendor's corporate office operations in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Activase 50 mg vials, a thrombolytic medication used in acute medical emergencies. This firm fixed-price delivery order, valued at $3,563.99, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...
- The Defense Logistics Agency awarded a $20,455.11 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Activase 50 mg vials, with an ultimate completion date of August 15, 2025. This is a firm fixed-price, non-set-aside contract issued to the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase on August 20, 2025, with a contract ceiling value of $3,662.41. This firm fixed-price delivery order, which carries an ultimate completion date of August 21, 2025, represents a competitively awarded non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ACTIVASE 50 mg vials, valued at $8,903.91, with a firm fixed price arrangement. This contract, issued on August 5, 2025, represents a direct fulfillment order with an ultimate completion date of August 6, 2025. The award was not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $21,231.29 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This delivery order (4566359301) awards AmerisourceBergen Drug Corp $5,729.42 to supply 50 milligram vials of Activase, a thrombolytic medication used to dissolve blood clots in acute medical emergencies. The contract was awarded on November 7, 2024, with an ultimate completion date of November 8, 2024, and represents a firm fixed-price delivery order with no set-aside designation. The award is funded by the Medical Supply Chain division of the Defense Logistics Agency and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, with a ceiling value of $17,807.88. This firm fixed-price contract was competitively awarded without set-aside designation and has an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,730.80 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. The contract, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price procurement with no set-aside designation. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated...